摘要
OBJECTIVE:Migraine is a common and frequently-occurring disease in neuromedicine.withunderstading of mechanism of migraine,new anti-migraine drugs have been found constantly to summarize theaspect of clinical application and progress on 5-HT1B/1D receptor agonist(Triptan).METHODS:To collectemedical literatures in recent years at home and abroad.CONCLUSION:Advance in 5-HT1B/1D receptor agonisthas been swiftly in recent years,it has higher selectivity to 5-HT1B/1D receptor,contraction of cerebralvessel and arteriae temporalis,efficacy being related to dosage,promoting distribution of blood flow,so 5-HT1B/1D receptor agonist(triptan) plays an important roles in treatment of migraine.
OBJECTIVE:Migraine is a common and frequently-occurring disease in neuromedicine.withunderstading of mechanism of migraine,new anti-migraine drugs have been found constantly to summarize theaspect of clinical application and progress on 5-HT1B/1D receptor agonist(Triptan).METHODS:To collectemedical literatures in recent years at home and abroad.CONCLUSION:Advance in 5-HT1B/1D receptor agonisthas been swiftly in recent years,it has higher selectivity to 5-HT1B/1D receptor,contraction of cerebralvessel and arteriae temporalis,efficacy being related to dosage,promoting distribution of blood flow,so 5-HT1B/1D receptor agonist(triptan) plays an important roles in treatment of migraine.
出处
《中国处方药》
2004年第2期54-58,共5页
Journal of China Prescription Drug